Efficacy of Anti-Pd1/pd-l1 Immunotherapy in Non–small Cell Lung Cancer is Dependent Upon Immunoscore IC CD8 and PD-L1 Status.

Journal of clinical oncology(2022)

引用 3|浏览37
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要